277 related articles for article (PubMed ID: 15233640)
1. Vascular endothelial growth factor (VEGF) receptor neuropilin-1's distribution in astrocytic tumors.
Broholm H; Laursen H
APMIS; 2004; 112(4-5):257-63. PubMed ID: 15233640
[TBL] [Abstract][Full Text] [Related]
2. Correlation of endothelial nitric oxide synthase and vascular endothelial growth factor expression with malignancy in patients with astrocytic tumors.
Erdamar S; Bagci P; Oz B; Dirican A
J BUON; 2006; 11(2):213-6. PubMed ID: 17318973
[TBL] [Abstract][Full Text] [Related]
3. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma.
Rempel SA; Dudas S; Ge S; Gutiérrez JA
Clin Cancer Res; 2000 Jan; 6(1):102-11. PubMed ID: 10656438
[TBL] [Abstract][Full Text] [Related]
4. Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A.
Lamszus K; Ulbricht U; Matschke J; Brockmann MA; Fillbrandt R; Westphal M
Clin Cancer Res; 2003 Apr; 9(4):1399-405. PubMed ID: 12684411
[TBL] [Abstract][Full Text] [Related]
5. Expression and distribution of id helix-loop-helix proteins in human astrocytic tumors.
Vandeputte DA; Troost D; Leenstra S; Ijlst-Keizers H; Ramkema M; Bosch DA; Baas F; Das NK; Aronica E
Glia; 2002 Jun; 38(4):329-38. PubMed ID: 12007145
[TBL] [Abstract][Full Text] [Related]
6. [p53 and vascular endothelial growth factor expression in astrocytoma and their relation to angiogenesis].
Ye S; Zhong X; Chen Y
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):326-9. PubMed ID: 11783119
[TBL] [Abstract][Full Text] [Related]
7. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in association with neovascularization in human primary astrocytoma.
Pan JW; Zhan RY; Tong Y; Zhou YQ; Zhang M
J Zhejiang Univ Sci B; 2005 Jul; 6(7):693-8. PubMed ID: 15973775
[TBL] [Abstract][Full Text] [Related]
8. Analysis of interleukin (IL)-8 expression in human astrocytomas: associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor, and microvessel morphometry.
Samaras V; Piperi C; Levidou G; Zisakis A; Kavantzas N; Themistocleous MS; Boviatsis EI; Barbatis C; Lea RW; Kalofoutis A; Korkolopoulou P
Hum Immunol; 2009 Jun; 70(6):391-7. PubMed ID: 19332096
[TBL] [Abstract][Full Text] [Related]
9. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
10. Tenascin expression in astrocytomas correlates with angiogenesis.
Zagzag D; Friedlander DR; Miller DC; Dosik J; Cangiarella J; Kostianovsky M; Cohen H; Grumet M; Greco MA
Cancer Res; 1995 Feb; 55(4):907-14. PubMed ID: 7531617
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of vascular endothelial growth factor isoforms drives oxygenation and growth but not progression to glioblastoma multiforme in a human model of gliomagenesis.
Sonoda Y; Kanamori M; Deen DF; Cheng SY; Berger MS; Pieper RO
Cancer Res; 2003 Apr; 63(8):1962-8. PubMed ID: 12702589
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical localization of basic fibroblast growth factor in astrocytomas.
Zagzag D; Miller DC; Sato Y; Rifkin DB; Burstein DE
Cancer Res; 1990 Nov; 50(22):7393-8. PubMed ID: 2171762
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor in human malignant astrocytomas.
Yamamoto M; Ikeda K; Ohshima K; Tsugu H; Kimura H; Tomonaga M
Cancer Res; 1997 Jul; 57(13):2799-805. PubMed ID: 9205092
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of tissue endostatin in human malignant gliomas.
Morimoto T; Aoyagi M; Tamaki M; Yoshino Y; Hori H; Duan L; Yano T; Shibata M; Ohno K; Hirakawa K; Yamaguchi N
Clin Cancer Res; 2002 Sep; 8(9):2933-8. PubMed ID: 12231538
[TBL] [Abstract][Full Text] [Related]
15. Microvessel density in brain tumors.
Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Papadakis N; Varakis I
Anticancer Res; 1997; 17(6D):4747-53. PubMed ID: 9494601
[TBL] [Abstract][Full Text] [Related]
16. Expression pattern of alpha-protein kinase C in human astrocytomas indicates a role in malignant progression.
Benzil DL; Finkelstein SD; Epstein MH; Finch PW
Cancer Res; 1992 May; 52(10):2951-6. PubMed ID: 1316231
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas.
Baumgarten P; Blank AE; Franz K; Hattingen E; Dunst M; Zeiner P; Hoffmann K; Bähr O; Mäder L; Goeppert B; Machein M; Seifert V; Steinbach JP; Plate KH; Harter PN; Mittelbronn M
Neuro Oncol; 2016 Feb; 18(2):173-83. PubMed ID: 26627848
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of epidermal growth factor receptor protein and c-erbB-2 oncoprotein in human astrocytic tumors. An immunohistochemical study.
Dietzmann K; von Bossanyi P
Zentralbl Pathol; 1994 Nov; 140(4-5):335-41. PubMed ID: 7826981
[TBL] [Abstract][Full Text] [Related]
19. Differences between phosphotyrosine accumulation and Neu/ErbB-2 receptor expression in astrocytic proliferative processes. Implications for glial oncogenesis.
Kristt DA; Yarden Y
Cancer; 1996 Sep; 78(6):1272-83. PubMed ID: 8826951
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
